Amarin Corp Plcuk (AMRN) Non Operating Income (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Non Operating Income of $188000.0 for Q1 2026, down 25.69% YoY from $253000.0 in Q1 2025, and down 93.53% sequentially from $2.9 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Non Operating Income (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Non Operating Income across 17 years of filings, most recently posting $188000.0 for Q1 2026.

  • In Q1 2026, Non Operating Income fell 25.69% year-over-year to $188000.0; the TTM figure through Mar 2026 stood at $3.2 million (up 3668.89% YoY), while the FY2025 annual figure was $3.3 million, up 172.77% from the prior year.
  • Non Operating Income slipped to $188000.0 in Q1 2026, from $2.9 million in the prior quarter.
  • Over the last five years, Non Operating Income for AMRN reached as high as $5.0 million in Q4 2023 and fell as low as -$2.3 million in Q2 2022.
  • The 5-year median for Non Operating Income is $253000.0 (2025), against an average of $704058.8.
  • The widest YoY moves for Non Operating Income: up 1320.45% in 2022, down 1080.63% in 2022.
  • A 5-year view of Non Operating Income shows it stood at $1.2 million in 2022, then soared by 296.0% to $5.0 million in 2023, then sank by 115.21% to -$753000.0 in 2024, then surged by 485.66% to $2.9 million in 2025, then sank by 93.53% to $188000.0 in 2026.
  • According to Business Quant data, Non Operating Income over the past three periods registered $188000.0, $2.9 million, and $205000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -65.00 Mn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -294.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -2.31 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -3.49 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -138.00 Mn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 75.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 235.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -861.00 Mn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn 188,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 188,000.00
Dec 31, 2025 2.90 Mn
Sep 30, 2025 205,000.00
Jun 30, 2025 -85,000.00
Mar 31, 2025 253,000.00
Dec 31, 2024 -753,000.00
Sep 30, 2024 265,000.00
Jun 30, 2024 145,000.00
Mar 31, 2024 1.55 Mn
Dec 31, 2023 4.95 Mn
Sep 30, 2023 -575,000.00
Jun 30, 2023 3.04 Mn
Mar 31, 2023 624,000.00
Dec 31, 2022 1.25 Mn
Sep 30, 2022 511,000.00
Jun 30, 2022 -2.26 Mn
Mar 31, 2022 -246,000.00
Dec 31, 2021 88,000.00
Sep 30, 2021 -57,000.00
Jun 30, 2021 -191,000.00